Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5416 Target Snapshot

Cyclin-dependent kinase 11A · SINGLE PROTEIN · Homo sapiens

291Compounds
105Assays
2Approved Drugs
184.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9UQ88. Use UniProt Q9UQ88 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9UQ88 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cyclin-dependent kinase 11A as ChEMBL target CHEMBL5416, mapped to UniProt Q9UQ88. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cyclin-dependent kinase 11A
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL5416
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9UQ88
Cyclin-dependent kinase 11A
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cyclin-dependent kinase 11A is the right protein anchor across sources, using UniProt Q9UQ88 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCyclin-dependent kinase 11A
UniProt AccessionQ9UQ88
Component TypeProtein
Sequence Length783 aa

Cyclin-dependent kinase 11A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cyclin-dependent kinase 11A, mapped to UniProt Q9UQ88. Sequence length is 783 aa.

Mapped IDQ9UQ88
Review nameCyclin-dependent kinase 11A
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
5
Phase II
2
Phase I
Assay Mix

Activity Type Distribution

IC5039.0
KD145.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4455382 8.77 IC50 1.7 Preclinical
CHEMBL445813 8.28 Kd 5.2 Clinical
CHEMBL1989043 7.48 Kd 33.0 Preclinical
CHEMBL5185990 7.42 Kd 38.0 Preclinical
CHEMBL5175800 7.41 Kd 39.0 Preclinical
CHEMBL5185655 7.37 Kd 43.0 Preclinical
CHEMBL296468 7.32 Kd 48.0 Preclinical
CHEMBL5200963 7.31 Kd 49.0 Preclinical
CHEMBL5180190 7.16 Kd 69.0 Preclinical
CHEMBL5184522 7.0 Kd 99.0 Preclinical
Distribution

pChEMBL Value Distribution

5
5.0
18
5.5
28
6.0
13
6.5
9
7.0
0
7.5
1
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

CRIZOTINIB
CHEMBL601719
Approved 2011
Assay Landscape

Assay Landscape

105
Total Assays
66
Tested Compounds
1
Assay Types
Binding — 105 assays, 66 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 72 19 6.4
assay format 16 22 6.6
subcellular format 10 0
cell-based format 7 25 6.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine